A PYMNTS Company

US: Eurex to appeal CME antitrust case ruling

By  |  December 3, 2018

According to the Financial Times, international exchange Eurex plans to appeal against the loss of a 15-year old lawsuit it brought against CME Group alleging the Chicago exchange had violated US antitrust laws to stop a rival venture from getting off the ground.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    The group, the derivatives bourse of Deutsche Börse, filed a notice confirming its intention in an Illinois district court late on Friday, November 30. It is trying to overturn a judge’s ruling a month ago, which found against Eurex’s charge that the CME and its subsidiary, the Chicago Board of Trade (CBOT), had broken rules in order to defend its home turf. Eurex declined to comment further.

    The move will prolong a case which dates back to 2003, but which the CME had felt was over. At the time under scrutiny, CBOT was independent, but has now been owned by the CME for more than a decade. CME declined to comment on Eurex’s filing.

    Full Content: Financial Times
    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.